| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.09. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 31.08. | BEAUTYFARM MED (02373): FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2025 (UPDATED) | - | HKEx | ||
| 31.08. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 28.08. | Beauty Farm Medical And Health Industry Inc. H1 Profit Climbs | 1 | RTTNews | ||
| BEAUTY FARM MEDICAL AND HEALTH INDUSTRY Aktie jetzt für 0€ handeln | |||||
| 28.08. | BEAUTYFARM MED Interim Net Profit Up 42.7% YoY to RMB222 million | 2 | AASTOCKS | ||
| 28.08. | BEAUTYFARM MED (02373): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 1 | HKEx | ||
| 19.08. | Dividendenbekanntmachungen (19.08.2026) | 8.424 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLIENT INC US0193301092 0,04 USD 0,0345 EUR APOLLO GLOBAL MANAGEMENT INC US03769M1062 0,5625 USD 0,4859 EUR AUDIOCODES LTD IL0010829658 0... ► Artikel lesen | |
| 13.08. | BEAUTYFARM MED (02373): DATE OF BOARD MEETING AND DATE OF PUBLICATION OF INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | - | HKEx | ||
| 05.08. | BEAUTYFARM MED (02373): CONNECTED TRANSACTION ACQUISITION OF EQUITY INTEREST IN SUBSIDIARIES OPERATING THE NATURADE BRAND | 1 | HKEx | ||
| 27.07. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 20.07. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 20.07. | BEAUTYFARM MED (02373): POSITIVE PROFIT ALERT | 2 | HKEx | ||
| 14.07. | BEAUTYFARM MED (02373): DISCLOSEABLE TRANSACTION SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS | - | HKEx | ||
| 10.07. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 02.07. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 26.06. | BEAUTYFARM MED (02373): THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION | - | HKEx | ||
| 26.06. | BEAUTYFARM MED (02373): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 26, 2026 | - | HKEx | ||
| 24.06. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 17.06. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 10.06. | BEAUTYFARM MED (02373): NEXT DAY DISCLOSURE RETURN | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 49,540 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | -0,05 % | BrightSpring Health Services auf Jefferies-Konferenz: Wachstum auf breiter Front | ||
| ALIGNMENT HEALTHCARE | 12,935 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| FRESENIUS | 45,665 | -0,09 % | AKTIE IM FOKUS: Fresenius ziehen an Dax-Spitze - UBS äußert sich zuversichtlich | FRANKFURT (dpa-AFX) - Die Aktien von Fresenius haben am Dienstag von einem positiven Analystenkommentar profitiert und so vorerst eine achttägige Verlustserie beendet. Die Papiere des Medizinkonzerns... ► Artikel lesen | |
| BASEL MEDICAL GROUP | 7,180 | +0,56 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,395 | +0,10 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,390 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 21,025 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| FRESENIUS MEDICAL CARE | 39,860 | +0,76 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen wegen des... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 6,520 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| GENEDX | 89,77 | +0,03 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BETA BIONICS | 16,710 | -0,12 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,040 | +0,13 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Siemens Healthineers auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| BILLIONTOONE | 100,78 | -0,04 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,880 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |